Skip to content
2000
image of Oxidized HDL as a Novel Predictive Biomarker in Conjunction with Selected Inflammatory Variables in Severe Dengue Fever Patients from Lahore, Pakistan

Abstract

Background

Dengue fever is a deadly disease and represents one of the biggest threats to global health, with persisting uncertainty surrounding its prognosis and treatment standards. The onset of severe dengue fever, characterized by intense inflammation and the production of pro-inflammatory molecules, is currently the only well-established association with disease severity. Therefore, identifying and assessing both new and established biomarkers that can accurately predict the outcome of severe dengue fever is essential.

Methods

In this study, 100 age-matched healthy controls and 100 hospitalized dengue patients positive for NS1 and IgM, with a mean age of 45 years (range: 22–65), were examined. Potential biomarkers were analyzed using a Coulter counter, spectroscopy, and ELISA to determine their prognostic value in assessing dengue fever severity.

Results

Triglycerides and very-low-density lipoproteins (VLDL) were significantly higher in severe dengue fever patients compared to controls (<0.001). Conversely, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and cholesterol levels were significantly lower in patients compared to controls (<0.001). Albumin levels were 40.9% lower, lactate dehydrogenase (LDH) was 422.1% higher, and C-reactive protein (CRP) levels were 435.6% higher in severe dengue fever patients compared to controls. Unlike HDL, oxidized HDL (oxHDL) levels were 160.4% higher in patients with severe dengue fever compared to controls. Still, the absolute levels of oxHDL did not exceed total HDL levels, as confirmed by corrected data.

Conclusion

Oxidized HDL, combined with other lipoproteins, may provide an ideal panel of prognostic indicators that could guide the treatment of severe dengue fever and serve as reliable biomarkers for predicting disease outcomes.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmm/10.2174/0115665240365589250519221441
2025-06-03
2025-09-14

  • From This Site

    /content/journals/cmm/10.2174/0115665240365589250519221441
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Colón-González F.J. Gibb R. Khan K. Watts A. Lowe R. Brady O.J. Projecting the future incidence and burden of dengue in Southeast Asia. Nat. Commun. 2023 14 1 5439 10.1038/s41467‑023‑41017‑y 37673859
    [Google Scholar]
  2. Zerfu B. Kassa T. Legesse M. Epidemiology, biology, pathogenesis, clinical manifestations, and diagnosis of dengue virus infection, and its trend in Ethiopia: A comprehensive literature review. Trop. Med. Health 2023 51 1 11 10.1186/s41182‑023‑00504‑0 36829222
    [Google Scholar]
  3. Wu B. Qi Z. Qian X. Recent advancements in mosquito-borne flavivirus vaccine development. Viruses 2023 15 4 813 10.3390/v15040813 37112794
    [Google Scholar]
  4. Ilic I. Ilic M. Global patterns of trends in incidence and mortality of dengue, 1990–2019: An analysis based on the Global Burden of Disease Study. Medicina 2024 60 3 425 10.3390/medicina60030425 38541151
    [Google Scholar]
  5. Rabeya Y. Wasek S. Dengue dynamics: A global update. Adv Hum Biol 2024 14 1 5 10 10.4103/aihb.aihb_135_23
    [Google Scholar]
  6. Afroz R. Das A.R. Taha A.R. Rahim A. Islam M.R. Clinical spectrum and risk factors of severe dengue among hospitalized patients - A cross-sectional study during the 2023 dengue epidemic in Bangladesh. J. Med. 2024 25 2 121 128 10.3329/jom.v25i2.74291
    [Google Scholar]
  7. Vuong N.L. Le Duyen H.T. Lam P.K. C-reactive protein as a potential biomarker for disease progression in dengue: A multi-country observational study. BMC Med. 2020 18 1 35 10.1186/s12916‑020‑1496‑1 32063229
    [Google Scholar]
  8. Thach T.Q. Eisa H.G. Hmeda A.B. Predictive markers for the early prognosis of dengue severity: A systematic review and meta-analysis. PLoS Negl. Trop. Dis. 2021 15 10 10.1371/journal.pntd.0009808 34610027 e0009808
    [Google Scholar]
  9. Shridhar P. Santosh S.C. Panda P.K. Rijal P. Dengue as an emerging infection and co-infections: An update. Biomed. Res. 2023 34 3 1 5
    [Google Scholar]
  10. Quirino-Teixeira A.C. Andrade F.B. Pinheiro M.B.M. Rozini S.V. Hottz E.D. Platelets in dengue infection: More than a numbers game. Platelets 2022 33 2 176 183 10.1080/09537104.2021.1921722 34027810
    [Google Scholar]
  11. Mohindra R.K.D. Kalyan M. The continuum of liver injury with severity of dengue fever: A retrospective observational study. J. R. Coll. Physicians Edinb. 2024 54 1 7 13 10.1177/14782715231216157 38112152
    [Google Scholar]
  12. Sangkaew S. Ming D. Boonyasiri A. Transaminases and serum albumin as early predictors of severe dengue – Authors’ reply. Lancet Infect. Dis. 2021 21 11 1489 1490 10.1016/S1473‑3099(21)00624‑1 34717803
    [Google Scholar]
  13. Ishak S.H. Yaacob L.H. Ishak A. Severe dengue with hemophagocytosis syndrome. Malays. Fam. Physician 2020 15 1 47 49 32284805
    [Google Scholar]
  14. Bur R. Suwarto S. Pohan H.T. Early intervention of 5% albumin shown superior control of vascular integrity and function compared to Ringer’s lactate in hospitalized adults with grade I & II dengue hemorrhagic fever: A multicenter randomized controlled trial in Indonesia. 2024 Res Sq 10.21203/rs.3.rs‑4324185/v1
    [Google Scholar]
  15. Marin-Palma D. Sirois C.M. Urcuqui-Inchima S. Hernandez J.C. Inflammatory status and severity of disease in dengue patients are associated with lipoprotein alterations. PLoS One 2019 14 3 e0214245 10.1371/journal.pone.0214245 30901375
    [Google Scholar]
  16. Palanichamy Kala M. St John A.L. Rathore A.P.S. Dengue: Update on clinically relevant therapeutic strategies and vaccines. Curr. Treat. Options Infect. Dis. 2023 15 2 27 52 10.1007/s40506‑023‑00263‑w 37124673
    [Google Scholar]
  17. Vijay J. Anuradha N. Anbalagan V.P. Clinical presentation and platelet profile of dengue fever: A retrospective study. Cureus 2022 14 8 e28626 10.7759/cureus.28626 36196330
    [Google Scholar]
  18. Moallemi S. Lloyd A.R. Rodrigo C. Early biomarkers for prediction of severe manifestations of dengue fever: A systematic review and a meta-analysis. Sci. Rep. 2023 13 1 17485 10.1038/s41598‑023‑44559‑9 37838744
    [Google Scholar]
  19. Hong C.G. Florida E. Li H. Parel P.M. Mehta N.N. Sorokin A.V. Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: A systematic review and meta-analysis. Front. Cardiovasc. Med. 2023 9 1023651 10.3389/fcvm.2022.1023651 36727024
    [Google Scholar]
  20. Itabe H. Obama T. The oxidized lipoproteins in vivo: Its diversity and behavior in the human circulation. Int. J. Mol. Sci. 2023 24 6 5747 10.3390/ijms24065747 36982815
    [Google Scholar]
  21. Kjeld M. An automated colorimetric method for the estimation of lactate dehydrogenase activity in serum. Scand. J. Clin. Lab. Invest. 1972 29 4 421 425 10.3109/00365517209080261 21488412
    [Google Scholar]
  22. Friedewald W.T. Levy R.I. Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972 18 6 499 502 10.1093/clinchem/18.6.499 4337382
    [Google Scholar]
  23. Shiota T. Li Z. Chen G.Y. Hepatoviruses promote very-long-chain fatty acid and sphingolipid synthesis for viral RNA replication and quasi-enveloped virus release. Sci. Adv. 2023 9 42 eadj4198 10.1126/sciadv.adj4198 37862421
    [Google Scholar]
  24. Durán A. Carrero R. Parra B. Association of lipid profile alterations with severe forms of dengue in humans. Arch. Virol. 2015 160 7 1687 1692 10.1007/s00705‑015‑2433‑z 25936955
    [Google Scholar]
  25. Välimäki I. Vuorimaa T. Ahotupa M. Vasankari T. Effect of continuous and intermittent exercises on oxidized HDL and LDL lipids in runners. Int. J. Sports Med. 2016 37 14 1103 1109 10.1055/s‑0042‑114703 27780284
    [Google Scholar]
  26. Suman J. Kumar S.R. Sonal S. Biochemical study of certain enzymes in dengue fever patients. Asian J. Pharm. Clin. Res. 2020 13 3 72 73 10.22159/ajpcr.2020.v13i3.36711
    [Google Scholar]
  27. Akkuş İ. Kaçmaz B. Acute phase reactants. Intercontl J Int Med 2024 2 3 74 76
    [Google Scholar]
  28. Kamath S.U. Rao R. Nayak S. Pandey A.K. Diagnostic performance of C-reactive protein level and its role as a potential biomarker of severe dengue in adults. Asian Pac. J. Trop. Med. 2020 13 8 358 365 10.4103/1995‑7645.289440
    [Google Scholar]
  29. Berretta M. Quagliariello V. Maurea N. Multiple effects of ascorbic acid against chronic diseases: Updated evidence from preclinical and clinical studies. Antioxidants 2020 9 12 1182 10.3390/antiox9121182 33256059
    [Google Scholar]
  30. Itabe H. Obama T. The oxidized lipoproteins in vivo: Its diversity and behavior in the human circulation. Int. J. Mol. Sci. 2023 24 6 5747
    [Google Scholar]
/content/journals/cmm/10.2174/0115665240365589250519221441
Loading
Oxidized HDL as a Novel Predictive Biomarker in Conjunction with Selected Inflammatory Variables in Severe Dengue Fever Patients from Lahore, Pakistan
Bentham Science Publishers ; https://doi.org/10.2174/0115665240365589250519221441
/content/journals/cmm/10.2174/0115665240365589250519221441
/content/journals/cmm/10.2174/0115665240365589250519221441
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: Ox HDL ; lipid profile ; Albumin ; dengue virus ; inflammatory markers

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test